• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Lifestyle interventions and certain medications reduce risk of diabetes in high risk individuals

byJames EnglandandAnees Daud
November 17, 2017
in Chronic Disease, Endocrinology, Gastroenterology, Psychiatry, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this meta-analysis of studies that evaluated the rate of diabetes development in high risk individuals, lifestyle modifications (LSM) and certain classes of medications were found to be effective at reducing risk.

2. Lifestyle modifications demonstrated a persistent effect on risk reduction for diabetes, while the observed effects from medications were short-lived.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Diabetes mellitus (DM) continues to be a growing health concern for many nations with significant associated morbidity and mortality. Many individuals can be identified as high risk for the development of diabetes and there has been much focus on strategies to reduce this risk. This study is a systematic review and meta-analysis of different interventions aimed at reducing the rate of diabetes in high risk individuals, and evaluated the short- and long-term effectiveness of those interventions. The study found that lifestyle interventions, including dietary changes and increased activity, demonstrated reduction in the risk of DM in both short- and long-term follow up. Medications including insulin sensitizers, and weight loss medications demonstrated comparable reduction in short-term risk of DM, but not in the long-term.

The observed long-term benefits of lifestyle interventions over the more short-term effects of medications may help inform policy and funding strategies aimed at reducing overall burden of DM. The study is methodologically rigorous and evaluates many studies. The main limitations include the high heterogeneity of treatment effects, and pooling of patients with both impaired fasting glucose, and impaired glucose tolerance.

Click to read the study, published in JAMA Internal Medicine

Relevant Reading: Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)

RELATED REPORTS

Faricimab may improve visual acuity in patients with diabetic macular edema

Supplementation of tirzepatide for type 2 diabetics on basal insulin improved glycemic control compared to placebo

Tirzepatide is superior to insulin glargine for management of type 2 diabetes and elevated cardiovascular risk

In-Depth [systematic review and meta-analysis]: This study is a meta-analysis of investigations from 1990 to 2015 that evaluated the effect of lifestyle and/or medication interventions on DM risk in patients with “prediabetes” defined with either impaired glucose tolerance, and/or impaired fasting glucose. Studies that included patients with established type 1 or 2 diabetes, or gestational diabetes were excluded. Studies that evaluated surgical interventions such as gastric bypass were also excluded.

The 43 studies encompassed 49 029 participants, with 19 studies of medications, 19 of lifestyle modifications (LSM), and 5 evaluating a combination approach. LSM was associated with a relative risk reduction of developing diabetes of 39% in the short-term follow up (RR, 0.61; 95%CI, 0.54-0.68) and 28% in the long-term (mean follow up of 7.2 years) (RR, 0.72; 95%CI, 0.60-0.86). Medications had a short-term risk reduction of 36% (RR, 0.64; 95%CI, 0.54-0.76) but no sustained response in long-term follow up. The most active medications included insulin sensitizing agents (metformin, rosiglitazone, and pioglitazone), and weight loss agents (orlistat, combination phentermine-topiramate). Angiotensin receptor blockers and α-Glucosidase inhibitors showed lower or more heterogeneous efficacy.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetes mellitus
Previous Post

Dabigatran shown to be a safe and effective alternative to warfarin for reducing stroke risk in atrial fibrillation

Next Post

Heart failure readmission prevention program may have inadvertent consequences

RelatedReports

Blindness and visual impairment decreasing worldwide
Chronic Disease

Faricimab may improve visual acuity in patients with diabetic macular edema

March 8, 2022
Insulin costs rose exponentially, regardless of formulation or patent
Cardiology

Supplementation of tirzepatide for type 2 diabetics on basal insulin improved glycemic control compared to placebo

February 9, 2022
Cardiology

Tirzepatide is superior to insulin glargine for management of type 2 diabetes and elevated cardiovascular risk

January 11, 2022
#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
StudyGraphics

#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes

December 2, 2021
Next Post
Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Heart failure readmission prevention program may have inadvertent consequences

Being overweight and obese associated with increased incidence of chronic kidney disease

Tolvaptan reduces eGFR decline in patients with polycystic kidney disease

AAP reaffirms support for adolescents’ rights to confidential reproductive care

Nonmedical prescription drug use associated with dating violence in adolescents

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
  • The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]
  • Relugolix combination therapy is efficacious for endometriosis-associated pain
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.